Avg closing price
Price range

9 Cathie Wood Beam Therapeutics Trades

Cathie Wood's position in Beam Therapeutics is currently worth $372 Million. That's 2.57% of their equity portfolio (15th largest holding). The investor owns 12.04% of the outstanding Beam Therapeutics stock. Cathie Wood started to build up the position in Beam Therapeutics in Q4 2020 and continued to invest until Q2 2022. Since then they sold 579 Thousand shares. The investor's estimated purchase price is $664 Million, resulting in a loss of 44%.

Avg closing price
Price range
Sold 3.3% shares (-278 Thousand shares) Q4 2022
Avg closing price $44.79
Price range $36.73 - $51.60
Sold 3.4% shares (-301 Thousand shares) Q3 2022
Avg closing price $57.05
Price range $39.79 - $70.31
Increased shares by 7.2% (+591 Thousand shares) Q2 2022
Avg closing price $39.75
Price range $29.86 - $62.36
Increased shares by 2.7% (+217 Thousand shares) Q1 2022
Avg closing price $65.59
Price range $53.73 - $82.16
Increased shares by 16.7% (+1.14 Million shares) Q4 2021
Avg closing price $85.62
Price range $68.02 - $99.06
Increased shares by 5.9% (+380 Thousand shares) Q3 2021
Avg closing price $100.46
Price range $84.37 - $133.60
Increased shares by 35.2% (+1.68 Million shares) Q2 2021
Avg closing price $79.68
Price range $64.12 - $128.71
Increased shares by 322.3% (+3.65 Million shares) Q1 2021
Avg closing price $95.13
Price range $71.28 - $120.75
New holding (+1.13 Million shares) Q4 2020
Avg closing price $49.18
Price range $22.24 - $95.63

News about Beam Therapeutics Inc and Cathie Wood

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!